RxDoctor Payments DataLook up a doctor →

Nichole Horn, PA

Physician Assistant · Hattiesburg, MSNPI 1467682385

Payments from drug & device makers

$18,695in general payments, 2019–2025

Across 1,115 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • UCB, Inc.$1K
  • AstraZeneca$1K
  • Acadia Pharmaceuticals Inc$1K
  • SK Life Science, Inc.$1K
  • Novartis$970
  • plus $11K from 50 others

What the payments were for

  • Speaking & faculty fees$110%
  • Food & beverage$18,53299%
  • Education$1521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)173$2,502
UCB, Inc.74$1,202
AstraZeneca(2 entities)61$1,107
Acadia Pharmaceuticals Inc79$1,086
SK Life Science, Inc.53$1,013
Novartis52$970
Pfizer60$847
Amgen(2 entities)44$822
Biogen44$708
Teva Pharmaceuticals USA, Inc.38$629
Neurocrine Biosciences, Inc.31$617
Lilly USA, LLC43$610
Genentech USA, Inc.29$598
Lundbeck LLC31$586
Eisai Inc.24$488
Argenx US, Inc.24$461
EMD Serono, Inc.27$445
Bristol Myers Squibb19$327
Merz Pharmaceuticals, LLC14$306
Biohaven Pharmaceutical Holding Company Ltd.19$293
Johnson & Johnson(2 entities)19$228
Takeda Pharmaceuticals U.S.A., Inc.10$226
Adamas Pharmaceuticals, Inc.11$205
Sunovion Pharmaceuticals Inc.14$190
Neurelis, Inc.11$184
Mallinckrodt Hospital Products Inc.7$169
Sanofi7$167
TG Therapeutics, Inc.9$152
Otsuka America Pharmaceutical, Inc.8$144
ANI Pharmaceuticals, Inc.7$138
Upsher-smith Laboratories LLC7$121
CSL Behring6$113
Jazz Pharmaceuticals Inc.4$102
Vanda Pharmaceuticals Inc.5$102
Tanabe Pharma America, Inc.6$90
Avanir Pharmaceuticals, Inc.6$81
Arbor Pharmaceuticals, Inc.6$80
Ipsen Biopharmaceuticals, Inc3$75
Banner Life Sciences, LLC3$59
MDD US Operations, LLC3$49
Azurity Pharmaceuticals, Inc.3$39
Supernus Pharmaceuticals, Inc.3$39
Axsome Therapeutics, Inc.2$37
Amneal Pharmaceuticals LLC2$34
Catalyst Pharmaceuticals, Inc.2$34
Collegium Pharmaceutical, Inc.2$34
Kyowa Kirin, Inc.1$24
Amylyx Pharmaceuticals, Inc.1$23
Life Molecular Imaging Ltd1$23
Almatica Pharma LLC1$20
Cycle Pharmaceuticals Inc1$20
Boston Scientific1$18
Revance Therapeutics, Inc.1$16
Sumitomo Pharma America, Inc.1$15
GE HealthCare1$14
Acorda Therapeutics, Inc1$11

How this compares

$18,695 in reported general payments places this provider in the 95th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$21,480
Medicare patients
156
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant62$100,626
Nurtec OdtRimegepant Sulfate66$84,740
Aimovig AutoinjectorErenumab-Aooe19$12,419
Emgality PenGalcanezumab-Gnlm11$9,871
Topiramate ErTopiramate16$7,040
Dalfampridine ErDalfampridine11$6,286
Quetiapine Fumarate25$3,104
Memantine Hcl74$3,009
Gabapentin170$2,314
Rivastigmine17$2,078
Carbidopa-LevodopaCarbidopa/Levodopa83$2,011
Methylphenidate Er (La)Methylphenidate Hcl11$1,599
Baclofen85$1,415
Levetiracetam37$1,273
Duloxetine Hcl72$1,178

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$2,502$100,62662 claims
PfizerNurtec Odt$847$84,74066 claims
Almatica Pharma LLCSertraline Hcl$20$59846 claims
Upsher-smith Laboratories LLCTopiramate$121$29244 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →